Target intelligence / Profile preview

Type III secretion system ATPase (SctN) (T3SS ATPase)

Target
T3SS ATPase
Molecular classification
Enzyme, ATPase, AAA+ ATPase family, Hydrolase
01

Overview

The Type III secretion system (T3SS) ATPase is a highly conserved enzyme essential for the virulence of numerous pathogenic Gram-negative bacteria, including Salmonella, Pseudomonas, and Shigella [1]. It belongs to the AAA+ family of ATPases and is responsible for providing the metabolic energy required to unfold and translocate effector proteins through the T3SS needle complex into host cells [2]. In the context of flagellar assembly, the homologous ATPase (FliI) powers the export of flagellar components required for bacterial motility [5]. Because these ATPases are critical for the delivery of virulence factors but are not required for basic bacterial survival, they represent promising targets for anti-virulence therapies that disarm pathogens without exerting the strong selective pressure for resistance seen with traditional antibiotics [4]. Current drug discovery efforts focus on small molecules that inhibit the catalytic activity or the essential hexameric oligomerization of the ATPase subunits [1, 2]. Sources: [1] Gao, X. et al. (2018) Front. Microbiol.; [2] Case, H. B. et al. (2020) Antibiotics; [3] UniProt (P0A1B3, O31043); [4] Burgess, E. R. et al. (2016) Expert Opin. Drug Discov.; [5] Minamino, T. & Namba, K. (2008) Nature.

Other names
Flagellar export ATPase (FliI)SctNFliIEscNInvCHrpNVscNYscNAAA+ ATPaseInjectisome ATPase
02

Mechanism of action

Inhibition of ATP hydrolysis activity, disruption of hexameric oligomerization, and blockade of effector protein translocation through the secretion channel.

03

Biological functions

Protein secretionVirulence factor translocationFlagellar assemblyATP hydrolysisBacterial motilityProtein unfolding
04

Disease associations

InfectionSalmonellosisShigellosisMelioidosisPlagueGastroenteritisRespiratory infection
05

Safety considerations

Structural homology with human mitochondrial F1-ATPase leading to potential off-target toxicity [1]Potential disruption of beneficial commensal Gram-negative bacteria [4]Challenges in achieving effective intracellular concentrations across the bacterial double membrane [2]
06

Interacting drugs

Aurodox

4 more in the full profile.

07

Biomarkers

Effector protein secretion levels (e.g., EspA, EspB, EspD)Tir translocationBacterial motilityNeedle complex assembly

Beyond the preview

Go deeper on Type III secretion system ATPase (SctN) (T3SS ATPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type III secretion system ATPase (SctN) (T3SS ATPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call